Search PubMed⌕ Search

Biomedical subjects

B Amsden

Publications and source records attributed to B Amsden.

6 recordsLinked to original sources
PubMed2002

Biodegradable injectable in situ forming drug delivery systems.

The ability to inject a drug incorporated into a polymer to a localized site and have the polymer form a semi-solid drug depot has a number of advantages. Among these advantages is ease of application and localized, prolonged drug delivery. For these reasons a large number of in situ setting polymeric delivery systems have been developed and investigated for use in delivering a wide variety of drugs. In this article we introduce the various strategies that have been used to prepare in situ setting systems, and outline their advantages and disadvantages as localized drug delivery systems.

Animals↗
PubMed2002

Camptothecin delivery methods.

Camptothecin has shown significant antitumor activity to lung, ovarian, breast, pancreas, and stomach cancers. Camptothecin, however, like a number of other potent anticancer agents such as paclitaxel, is extremely water insoluble. Furthermore, pharmacology studies have determined that prolonged schedules of administration given continuously are required. Thus, this insolubility has restricted its clinical application. For these reasons, a number of water-soluble analogs have been synthesized and a number of different formulation approaches have been investigated. In this review, we examine each of these approaches and discuss their advantages and limitations.

Animals↗
PubMed1999

Diffusion characteristics of calcium alginate gels.

The diffusivity of a protein solute (bovine serum albumin) within calcium alginate gels made from sodium alginate of different guluronic acid content was determined. It was found that protein diffusion within alginate gels, prepared to be isotropic in structure, was greatest for gels prepared from sodium alginate of low guluronic acid content as opposed to those prepared from sodium alginate of high guluronic acid content. This finding was explained in terms of the difference in flexibility of the polymer backbone of the two alginates. The greater the polymer backbone flexibility, the greater the solute diffusivity within the gel.

Alginates↗
PubMed1994

Controlled release of albumin from chitosan-alginate microcapsules.

A polymeric delayed-release protein delivery system was investigated with albumin as a model drug. The polysaccharide chitosan was reacted with sodium alginate in the presence of calcium chloride to form microcapsules with a polyelectrolyte complex membrane. Variables believed to be important for membrane formation were examined; these included reaction time, chitosan molecular weight, alginate concentration, chitosan concentration, and solution pH. An alginate-chitosan reaction time, in the range of 10 to 45 min, had no effect on the release of albumin. Increasing the alginate concentration, however, resulted in a decreased rate of release of albumin (from 37% release at 4 h with 1.5% alginate to 20% release with 2.5% alginate). Another key variable was the chitosan molecular weight. The molecular weight of chitosan was varied from 1.25 x 10(6) to 0.25 x 10(6) through a nitrite oxidation reaction with sodium nitrite. Decreasing the molecular weight increased the release of albumin (from 37% release at 4 h with high molecular weight chitosan to 77% release with low molecular weight chitosan). The pH of the extracapsular environment was found to affect the release of albumin significantly (15% release over 24 h at a pH 3.0 and 73% release at pH 8.0). Capsules produced with high molecular weight chitosan and a combination of high and low molecular weight chitosan gave the best results for reducing elution of albumin in the first 4 h and increasing elution in the following 20 h.

Albumins↗
PubMedDate not supplied

Modulation of protein release from chitosan-alginate microcapsules using the pH-sensitive polymer hydroxypropyl methylcellulose acetate succinate.

The release characteristics of protein from chitosan-alginate microcapsules prepared using an electrostatic droplet generator were evaluated. The release studies were undertaken in-vitro in simulated gastrointestinal fluids covering the pH range 1.2-8. Chitosan-alginate microcapsules showed unsatisfactory release properties, losing 94% of the encapsulated proteins (bovine serum albumin) over a 24 h period at pH 1.2. Incorporation of a pH-sensitive polymer, hydroxypropyl methylcellulose acetate succinate (HPMCAS), in the microcapsules, by coating the capsule membrane as well as blending with the capsule core polymer in varying ratios, produced significant changes in the release profiles of the microcapsules. At pH 1.2, the modified microcapsules retained up to 60% of the encapsulated protein after 24 h. The results obtained highlight the potential of HPMCAS as a release-modifier in chitosan-alginate microcapsules.

Aerosols↗